About Rubinstein-Taybi syndrome due to CREBBP mutations
Rubinstein-Taybi syndrome due to CREBBP mutations is a rare disease catalogued by Orphanet (ORPHA:353277). It is associated with the CREBBP gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Rubinstein-Taybi syndrome due to CREBBP mutations trials.
Search ClinicalTrials.gov for "Rubinstein-Taybi syndrome due to CREBBP mutations" or filter by Orphanet code ORPHA:353277 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Rubinstein-Taybi syndrome due to CREBBP mutations trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Rubinstein-Taybi syndrome due to CREBBP mutations. Updated daily.